Login / Signup

Development of a Biomarker-Based Scoring System Predicting Early Recurrence of Resectable Pancreatic Duct Adenocarcinoma.

Keinosuke IshidoNorihisa KimuraTaiichi WakiyaHayato NagaseYutaro HaraTaishu KandaHiroaki FujitaKenichi Hakamada
Published in: Annals of surgical oncology (2021)
For R-PDAC, ER could be predicted by the scoring system using preoperative serum CA19-9 and SPan-1 levels and CT tumor diameter, which may have great significance in identifying patients with poor prognoses and avoiding unnecessary surgery.
Keyphrases